Basic & Translational Cardiovascular Medicine Research

Research on the Determinants of Heart Disease

Basic laboratory research in the Division of Cardiovascular Medicine at Beth Israel Deaconess Medical Center (BIDMC) includes investigations to identify the genetic, molecular, and functional determinants that underlie heart disease.

Some of our researchers are working to develop new ways to protect the heart during cancer therapy. What they learn from cancer drugs may help us understand how heart disease arises in patients without cancer. In looking at the molecular mechanisms of chemotherapy-associated heart toxicity, our team may be able to target these pathways therapeutically in patients.

Our division is also at the forefront of cardiometabolic research. Using metabolomic and proteomic plasma profiling techniques to make observations in humans can be brought back to the bench for biomarker and pathway discovery in cardiometabolic disease.

Other areas of focus include studying the molecular mechanisms of processes that play an important role in various cardiovascular functions and conditions such as thrombosis, myocardial infarction, and heart failure. See additional information below in our list of faculty.

Contact Us

Please contact the Division of Cardiovascular Medicine Research if you have any questions. 

Meet the Team

Aarti Asnani, MD
Aarti Asnani, MD Asnani Lab Research Area Cardio-oncology, Cardiovascular toxicity, Basic and translational science
Mark Benson, MD, PhD
Mark Benson, MD, PhD Director, Preventive Cardiology Benson Lab Research Area Preventive Cardiology, Multi-Omics Profiling, Basic Science Research
Peter Kang, MD
Peter Kang, MD Research Area Nanotechnology, Ischemia reperfusion therapy, Heart failure
BILH Headshot Avatar
Anjali Nath, PhD Research Area Metabolic Diseases, Zebrafish Genetics, Drug Discovery
Alec Schmaier, MD, PhD
Alec Schmaier, MD, PhD Research Area Thrombosis, Vascular Biology, Extracellular Vesicles
BILH Headshot Avatar
Richard Verrier, PhD Research Area ECG alternans and heterogeneity, Arrhythmia risk, The Epileptic Heart